Hepatitis C Articles (HCV)
Back
 
Clinical Pharmacokinetics and Antiviral Activity of CC-31244, a Pan-genotypic, Potent Nonnucleoside NS5B Polymerase Inhibitor (NNI) for the Treatment of Hepatitis C
Reported by Jules Levin
2017 APASL, Shanghai
Sam Lee, Ph.D.
View Older Articles
Back to Top
www.natap.org